GFAP and Alzheimer disease: Furthermore, the elevated plasma GFAP and NfL levels preceded altered Aβ1-42/Aβ1-40 and p-Tau181 levels, indicating that plasma GFAP and NfL levels may reflect extensive reactive astrogliosis and neuronal damage in PD before the onset of AD-related neurodegeneration [70,75].